Vaxart, Inc. (VXRT)
Data as of , from SEC Form 4 filings.
See up to 3 months of VXRT. The 7-day demo opens the 1M and 3M ranges and puts VXRT on your watchlist.
Start 7-day demoLatest VXRT insider trades
About Vaxart, Inc. (VXRT)
VXRT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 10 | 497,325 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VXRT insider transactions (Form 4)
4831 Form 4 filings on record, the earliest from Dec 17, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kevin Finney - Director | Grant or award | Common Stock | 39,400 footnote F1 | $0.00 | - | |
| Kevin Finney - Director | Grant or award | Stock Options (right to buy) | 78,700 | $0.00 | - | |
| ||||||
 James B. Breitmeyer - Director | Grant or award | Common Stock | 8,315 footnote F1 | $0.00 | - | |
| James B. Breitmeyer - Director | Grant or award | Stock Options (right to buy) | 16,610 | $0.00 | - | |
| ||||||
| Elaine J. Heron - Director | Grant or award | Common Stock | 39,400 footnote F1 | $0.00 | - | |
| Elaine J. Heron - Director | Grant or award | Stock Options (right to buy) | 78,700 | $0.00 | - | |
| ||||||
| W. Mark Watson - Director | Grant or award | Common Stock | 39,400 footnote F1 | $0.00 | - | |
| W. Mark Watson - Director | Grant or award | Stock Options (right to buy) | 78,700 | $0.00 | - | |
| ||||||
 David E. Wheadon - Director | Grant or award | Common Stock | 39,400 footnote F1 | $0.00 | - | |
| David E. Wheadon - Director | Grant or award | Stock Options (right to buy) | 78,700 | $0.00 | - | |
| ||||||
| W. Mark Watson - Director | Open-market purchase | Common Stock | 10,000 | $0.65 | $7K | |
| Jeroen Nicolaas Grasman - Officer | Tax withholding / forfeiture | Common Stock | 31,395 footnote F1 | $0.61 | $19K | |
| ||||||
| James B. Breitmeyer - Director | Grant or award | Common Stock | 78,800 footnote F1 | $0.00 | - | |
| James B. Breitmeyer - Director | Grant or award | Stock Option (right to buy) | 157,400 | $0.00 | - | |
| ||||||
| Sean Tucker - Officer | Tax withholding / forfeiture | Common Stock | 3,924 footnote F1 | $0.65 | $3K | |
| ||||||
| James F. Cummings - Officer | Tax withholding / forfeiture | Common Stock | 3,292 footnote F1 | $0.65 | $2K | |
| ||||||
 Edward B. Berg - Officer | Tax withholding / forfeiture | Common Stock | 36,418 footnote F1 | $0.69 | $25K | |
| ||||||
| James F. Cummings - Officer | Tax withholding / forfeiture | Common Stock | 30,551 footnote F1 | $0.69 | $21K | |
| ||||||
 Steven Lo - Officer | Tax withholding / forfeiture | Common Stock | 126,028 footnote F1 | $0.69 | $87K | |
| ||||||
| Sean Tucker - Officer | Tax withholding / forfeiture | Common Stock | 36,418 footnote F1 | $0.69 | $25K | |
| ||||||
| Edward B. Berg - Officer | Tax withholding / forfeiture | Common Stock | 8,072 footnote F1 | $0.63 | $5K | |
| ||||||
| James F. Cummings - Officer | Tax withholding / forfeiture | Common Stock | 6,772 footnote F1 | $0.63 | $4K | |
| ||||||
| Steven Lo - Officer | Tax withholding / forfeiture | Common Stock | 22,425 footnote F1 | $0.63 | $14K | |
| ||||||
| Sean Tucker - Officer | Tax withholding / forfeiture | Common Stock | 8,072 footnote F1 | $0.63 | $5K | |
| ||||||
| Steven Lo - Officer | Grant or award | Common Stock | 846,500 footnote F1 | $0.00 | - | |
| Steven Lo - Officer | Grant or award | Stock Option (right to buy) | 1,543,000 | $0.00 | - | |
| ||||||
| Sean Tucker - Officer | Grant or award | Common Stock | 200,000 footnote F1 | $0.00 | - | |
| Sean Tucker - Officer | Grant or award | Stock Option (right to buy) | 410,000 | $0.00 | - | |
| ||||||
| Jeroen Nicolaas Grasman - Officer | Grant or award | Common Stock | 227,000 footnote F1 | $0.00 | - | |
| Jeroen Nicolaas Grasman - Officer | Grant or award | Stock Option (right to buy) | 455,000 | $0.00 | - | |
| ||||||
| James F. Cummings - Officer | Grant or award | Common Stock | 227,000 footnote F1 | $0.00 | - | |
| James F. Cummings - Officer | Grant or award | Stock Option (right to buy) | 455,000 | $0.00 | - | |
| ||||||
| Edward B. Berg - Officer | Grant or award | Common Stock | 115,000 footnote F1 | $0.00 | - | |
| Edward B. Berg - Officer | Grant or award | Stock Option (right to buy) | 225,000 | $0.00 | - | |
| ||||||
| James F. Cummings - Officer | Tax withholding / forfeiture | Common Stock | 7,965 footnote F1 | $0.61 | $5K | |
| ||||||
| Edward B. Berg - Officer | Tax withholding / forfeiture | Common Stock | 9,265 footnote F1 | $0.61 | $6K | |
| ||||||
| Sean Tucker - Officer | Tax withholding / forfeiture | Common Stock | 9,265 footnote F1 | $0.61 | $6K | |
| ||||||
| Elaine J. Heron - Director | Open-market purchase | Common Stock | 23,217 | $0.39 | $9K | |
| Elaine J. Heron - Director | Open-market purchase | Common Stock | 16,783 | $0.41 | $7K | |
| Kevin Finney - Director | Open-market purchase | Common Stock | 794 | $0.38 | $302 | |
| Kevin Finney - Director | Open-market purchase | Common Stock | 20,000 | $0.39 | $8K | |
| Kevin Finney - Director | Open-market purchase | Common Stock | 20,000 | $0.40 | $8K | |
| Kevin Finney - Director | Open-market purchase | Common Stock | 25,874 | $0.38 | $10K | |
| Kevin Finney - Director | Open-market purchase | Common Stock | 50,000 | $0.35 | $18K | |
| Kevin Finney - Director | Open-market purchase | Common Stock | 50,000 | $0.37 | $19K | |
| W. Mark Watson - Director | Open-market purchase | Common Stock | 10,000 | $0.41 | $4K | |
| Elaine J. Heron - Director | Grant or award | Common Stock | 16,000 | $0.00 | - | |
| Elaine J. Heron - Director | Grant or award | Stock Option (right to buy) | 95,400 | $0.00 | - | |
Item 8.01
Item 8.01
Item 2.02, 9.01
Item 8.01
VXRT insider trading FAQ
What is the latest insider trade for VXRT?
Vaxart, Inc. (VXRT) had 5 insider filings in the last 90 days, with the most recent on 2026-07-20. The full record for VXRT runs to 31 Form 4 filings, the earliest from 2024-12-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VXRT stock?
No insider purchases of VXRT were filed in the last 90 days. 10 purchases are on record for this company.
How many insiders are selling VXRT stock?
No insider sales of VXRT were filed in the last 90 days.
Where can I see VXRT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VXRT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kevin Finney view on EDGAR
- - James B. Breitmeyer view on EDGAR
- - Elaine J. Heron view on EDGAR
- - W. Mark Watson view on EDGAR
- - David E. Wheadon view on EDGAR
- - W. Mark Watson view on EDGAR
- - Jeroen Nicolaas Grasman view on EDGAR
- - James B. Breitmeyer view on EDGAR
- - Sean Tucker view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VXRT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VXRT with a 7-day demo
- VXRT on your watchlist
- Every VXRT Form 4 filing on record
- Up to 3 months of VXRT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
